Literature DB >> 14578343

Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.

Maria Rodriguez1, Xiaochun Yu, Junjie Chen, Zhou Songyang.   

Abstract

Protein phosphorylation by protein kinases may generate docking sites for other proteins. It thus allows the assembly of signaling complexes in response to kinase activation. Several protein domains that bind phosphoserine or phosphothreonine residues have been identified, including the 14-3-3, PIN1, FHA, KIX, WD-40 domain, and polo box (Yaffe, M. B., and Elia, A. E. (2001) Curr. Opin. Cell Biol. 13, 131-138; Elia, A. E., Cantley, L. C., and Yaffe, M. B. (2003) Science 299, 1228-1231). The BRCA1 COOH-terminal (BRCT) domains are protein modules found in many proteins that regulate DNA damage responses (Koonin, E. V., Altschul, S. F., and Bork, P. (1996) Nat. Genet. 13, 266-268). Whether BRCT domains can mediate phosphorylation-dependent interactions has not been systematically investigated. We report here that the BRCT domains also recognize phosphopeptides. Oriented peptide library analysis indicated that the BRCT domains from BRCA1, MDC1, BARD1, and DNA Ligase IV preferred distinct phosphoserine-containing peptides. In addition, the interaction between BRCA1 and the BRCT binding motif of BACH1 was required for BACH1 checkpoint activity. Furthermore, BRCT domains of the yeast DNA repair protein Rad9 could bind phosphopeptides, suggesting that the BRCT domains represent a class of ancient phosphopeptide-binding modules. Potential targets of BRCT domains were identified through data base search. Structural analysis of BRCA1 BRCT repeats also predicted conserved residues that may form the phosphopeptide-binding pocket. Thus, the BRCT repeats are a new family of phosphopeptide-binding domains in DNA damage responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578343     DOI: 10.1074/jbc.C300407200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  97 in total

1.  Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.

Authors:  Maria Victoria E Botuyan; Yves Nominé; Xiaochun Yu; Nenad Juranic; Slobodan Macura; Junjie Chen; Georges Mer
Journal:  Structure       Date:  2004-07       Impact factor: 5.006

2.  TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival.

Authors:  Kang Liu; Yuhong Luo; Fang-Tsyr Lin; Weei-Chin Lin
Journal:  Genes Dev       Date:  2004-03-15       Impact factor: 11.361

3.  Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.

Authors:  Caroline M S Ekblad; Assaf Friedler; Dmitry Veprintsev; Richard L Weinberg; Laura S Itzhaki
Journal:  Protein Sci       Date:  2004-03       Impact factor: 6.725

Review 4.  BRCA1-directed, enhanced and aberrant homologous recombination: mechanism and potential treatment strategies.

Authors:  Seth M Dever; E Railey White; Matthew C T Hartman; Kristoffer Valerie
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

5.  Molecular basis of BACH1/FANCJ recognition by TopBP1 in DNA replication checkpoint control.

Authors:  Charles Chung Yun Leung; Zihua Gong; Junjie Chen; J N Mark Glover
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

6.  XLF regulates filament architecture of the XRCC4·ligase IV complex.

Authors:  Michal Hammel; Yaping Yu; Shujuan Fang; Susan P Lees-Miller; John A Tainer
Journal:  Structure       Date:  2010-11-10       Impact factor: 5.006

7.  DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains.

Authors:  Xiaochun Yu; Junjie Chen
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.

Authors:  Xiaochun Yu; Shuang Fu; Maoyi Lai; Richard Baer; Junjie Chen
Journal:  Genes Dev       Date:  2006-07-01       Impact factor: 11.361

9.  Assessment of functional effects of unclassified genetic variants.

Authors:  Fergus J Couch; Lene Juel Rasmussen; Robert Hofstra; Alvaro N A Monteiro; Marc S Greenblatt; Niels de Wind
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

10.  Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1.

Authors:  Yang Shen; Liang Tong
Journal:  Biochemistry       Date:  2008-05-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.